康拓医疗
(688314)
| 流通市值：7.88亿 | | | 总市值：17.46亿 |
| 流通股本：3668.78万 | | | 总股本：8123.92万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 69,917,918.34 | 275,025,921.27 | 206,601,313.31 | 135,126,592.44 |
| 营业收入 | 69,917,918.34 | 275,025,921.27 | 206,601,313.31 | 135,126,592.44 |
| 二、营业总成本 | 44,390,295.19 | 178,155,211.19 | 129,328,527.09 | 87,116,112.8 |
| 营业成本 | 13,130,989.47 | 51,752,067.44 | 39,024,939.42 | 25,563,568.11 |
| 税金及附加 | 1,189,336.35 | 4,839,601.89 | 3,709,352.5 | 2,417,901.28 |
| 销售费用 | 13,047,392.17 | 55,056,313.4 | 40,878,290.54 | 28,784,575.31 |
| 管理费用 | 13,016,006.28 | 52,277,352.87 | 35,308,964.54 | 23,485,087.94 |
| 研发费用 | 4,655,270.57 | 17,637,641.56 | 13,734,653.11 | 8,275,666.55 |
| 财务费用 | -648,699.65 | -3,407,765.97 | -3,327,673.02 | -1,410,686.39 |
| 其中:利息费用 | 541,662.43 | 1,893,256.93 | 1,395,938.38 | 890,638.06 |
| 其中:利息收入 | 1,389,515.93 | 5,198,947.27 | 4,531,621.78 | 1,937,791.9 |
| 加:投资收益 | -2,201,609.87 | -1,864,265.12 | -258,869.12 | 132,450.47 |
| 净敞口套期收益 | - | 0 | - | - |
| 资产处置收益 | - | -35,376.8 | -35,376.8 | -35,376.8 |
| 资产减值损失(新) | -587,257.3 | -8,628,619.65 | -3,600,865.81 | -1,923,658.82 |
| 信用减值损失(新) | 226,872.28 | -163,968.99 | -19,015.37 | -136,642.2 |
| 其他收益 | 1,315,270.08 | 5,254,080.8 | 3,457,862.93 | 963,081.68 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 24,280,898.34 | 91,432,560.32 | 76,816,522.05 | 47,010,333.97 |
| 加:营业外收入 | 0.99 | 469,573.98 | 272,760.29 | 9,290.86 |
| 减:营业外支出 | - | 149,669 | 34,899.93 | 34,871.88 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 24,280,899.33 | 91,752,465.3 | 77,054,382.41 | 46,984,752.95 |
| 减:所得税费用 | 4,659,325.23 | 17,279,551.35 | 13,410,377.8 | 8,407,323.34 |
| 六、净利润 | 19,621,574.1 | 74,472,913.95 | 63,644,004.61 | 38,577,429.61 |
| 持续经营净利润 | 19,621,574.1 | 74,472,913.95 | 63,644,004.61 | 38,577,429.61 |
| 归属于母公司股东的净利润 | 19,935,123.47 | 75,510,975.16 | 64,346,824.69 | 39,180,316.14 |
| 少数股东损益 | -313,549.37 | -1,038,061.21 | -702,820.08 | -602,886.53 |
| (一)基本每股收益 | 0.25 | 0.93 | 0.79 | 0.48 |
| (二)稀释每股收益 | 0.25 | 0.93 | 0.79 | 0.48 |
| 八、其他综合收益 | -401,085.94 | -469,895.99 | 103,528.65 | 230,319.92 |
| 归属于母公司股东的其他综合收益 | -399,085.34 | -449,198.52 | 135,579.96 | 280,591.03 |
| 九、综合收益总额 | 19,220,488.16 | 74,003,017.96 | 63,747,533.26 | 38,807,749.53 |
| 归属于母公司股东的综合收益总额 | 19,536,038.13 | 75,061,776.64 | 64,482,404.65 | 39,460,907.17 |
| 归属于少数股东的综合收益总额 | -315,549.97 | -1,058,758.68 | -734,871.39 | -653,157.64 |
| 公告日期 | 2024-04-26 | 2024-04-13 | 2023-10-27 | 2023-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |